Skip to main content

Table 5 Resource use, utilities and work loss per 3-month period by number of headache days per month

From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Health State GP/A&E Visits Avg. number of days absent Utilities (EQ-VAS)
Mean SD
0–3 headache days 0.82 1.44 0.776 0.144
4–9 headache days 1.24 3.52 0.702 0.167
10–14 headache days 1.34 8.41 0.631 0.180
15–19 headache days 1.49 6.81 0.615 0.181
20–23 headache days 2.41 19.40 0.474 0.217
24+ headache days 2.49 28.22 0.468 0.231
  1. Key: A&E Accident and emergency; GP General practitioner; HA Headache